Multivariate analysis indicated IL4Rα-positivity and co-expression of IL4Rα and IL13Rα1 as the independent indicators of shorter CSS and RFS of CCRCC patients. This evidence concerns the gene IL4R and nonpapillary renal cell carcinoma.